Voyager Therapeutics Inc. on Friday registered with the Securities and Exchange Commission for an initial public offering of up to $86.3 million. Voyager reported a loss of $18.5 million and collaboration revenue of $7.5 million in the first six months of 2015. Its biggest shareholder with a 52.6% stake is Third Rock Ventures L.P., according to its SEC filing. The company plans to list its shares on the Nasdaq Global Market under the ticker "VYGR."
Copyright © 2015 MarketWatch, Inc.